Zhejiang Provincial People's Hospital

This early-phase trial is testing an experimental therapy called WTX-212C, which uses specially engineered red blood cells to treat advanced solid tumors. The study will enroll 24 adults whose cancer has not responded to standard treatments. The main goal is to check safety and f…

This study tests two drugs, sacituzumab tirumotecan and tislelizumab, in people with advanced thyroid cancer that has stopped responding to standard treatments. The goal is to see if these drugs can shrink tumors or help people live longer. About 94 adults with three types of har…

This study is testing whether a combination of two drugs, telitacicept and baricitinib, can help people with difficult-to-treat rheumatoid arthritis. The trial will enroll 30 adults aged 18 to 85 who have not responded to other treatments. Researchers will measure joint swelling …

This early-phase study is testing whether adding low-dose radiation and an immunotherapy drug called pucotenlimab to standard chemotherapy can help control advanced pancreatic cancer. Ten adults with pancreatic cancer who haven't had prior immunotherapy will receive the combinati…

This study tests whether a once-daily combination of henagliflozin and metformin works better than standard metformin alone in people newly diagnosed with type 2 diabetes. 268 adults will take either the combo pill or metformin twice a day for 24 weeks. Researchers will measure c…

DREAM-10 is a 10-year observational study that follows 1,000 adults aged 30 to 60 who have imaging signs of cerebral small vessel disease but no known dementia. Researchers collect clinical data, memory and thinking tests, brain MRI scans, and detailed eye imaging to track how th…